Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
Mouquet
C
C
Kidney and Pancreatic Transplantation Unit, Pitié Salpêtrière Hospital, Paris, France.
Bernard
B
B
Poynard
T
T
Thibault
V
V
Opolon
P
P
Coriat
P
P
Bitker
M O
MO
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D011183:Postoperative Complications; D012189:Retrospective Studies
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine; D016572:Cyclosporine